Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024.
- Revenue
- +0.55%
- EPS
- −85.0%
- Free cash flow
- +154.2%
- Total debt
- −4.96%
Quarter to September 2026, against a year earlier
Follow PHG
Alert me
Koninklijke Philips N.V. (PHG) P/E ratio
As of 5 November 2026, Koninklijke Philips N.V. (PHG) trades at a P/E ratio of 25.8×. Over the past ten years it has ranged from 0.0× (September 2024) to 59.0× (April 2015); the current reading is higher than 65% of that period. That is in line with the Medical Devices industry median of 25.6× and in line with the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 24.9× | (8.66%) |
| FY2024 | 27.2× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 4.3× | (82.97%) |
| FY2020 | 25.5× | 50.32% |
| FY2019 | 17.0× | 37.93% |
| FY2018 | 12.3× | (28.23%) |
| FY2017 | 17.1× | 6.23% |
| FY2016 | 16.1× | (49.89%) |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 20.7× | 4.06% |
| Jun 2026 | 19.9× | (13.09%) |
| Mar 2026 | 22.9× | (8.10%) |
| Dec 2025 | 24.9× | (26.11%) |
| 37 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| GKOS Glaukos Corporation compare | n/m |
| GEHC GE HealthCare Technologies Inc. compare | 17.5× |
| BSX Boston Scientific Corporation compare | 18.7× |
| PHG Koninklijke Philips N.V. | 25.8× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 26.9× |
| STE STERIS plc compare | 30.0× |
| DXCM DexCom, Inc. compare | 32.6× |
| SNN Smith & Nephew SNATS, Inc. compare | 38.9× |
| EW Edwards Lifesciences Corporation compare | 56.7× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on PHG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement